SCHEMBL25620239

SCHEMBL25620239

CCc1ccc(C/C=N/N=C/Cc2ccc(CC)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.43
TP53 P04637 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
CYP2C9 P11712 1/20 0.41
PLAU P00749 1/20 0.40
CYP2A6 P11509 1/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
PLK1 P53350 1/20 0.39
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
CA2 P00918 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25620328 0.81 LPL (0.43) LPLLIPGPLK1ALDH1A1CA2
Hydrochloric Acid SCHEMBL5703258 0.80 IDO1 (0.49) IDO1PLAUSMN1; SMN2MAOA
SCHEMBL25620226 0.80 IDO1 (0.44) IDO1TP53TAAR1CYP2A6SMN1; SMN2
SCHEMBL25620232 0.78 TP53 (0.41) IDO1TP53CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL25620242 0.75 ESR1 (0.48) IDO1TAAR1ALDH1A1CA2TDP1
SCHEMBL36295 0.74 TP53 (0.67) IDO1TP53TAAR1PLAUCYP2A6
SCHEMBL25271061 0.74 MAOB (0.57) IDO1TP53ALDH1A1CA2TSHR
SCHEMBL9249830 0.74 TP53 (0.46) IDO1TP53TAAR1CYP2C9PLAU
SCHEMBL2557761 0.74 ALDH1A1 (0.46) IDO1TP53TAAR1CYP2C9CYP2A6
SCHEMBL4037964 0.74 MAOB (0.57) IDO1TP53ALDH1A1CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114453-A1 PHENYLETHYLIDENEHYDRAZINE DIMERS AND METHODS OF USING SAME Neurawell Therapeutics (US) 2023-06-22 WO disclosed